AW
DGX icon

ACG Wealth’s Quest Diagnostics DGX Stock Holding History

ACG Wealth’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2.06M Buy
16,754
+171
+1% +$22.5K 0.47% 64
2022
Q2 		$2.21M Buy
16,583
+346
+2% +$47.1K 0.45% 60
2022
Q1 		$2.22M Buy
16,237
+1,728
+12% +$241K 0.42% 73
2021
Q4 		$2.51M Buy
14,509
+227
+2% +$34.5K 0.36% 67
2021
Q3 		$2.08M Sell
14,282
-1,694
-11% -$248K 0.27% 81
2021
Q2 		$2.11M Buy
15,976
+4,421
+38% +$579K 0.27% 82
2021
Q1 		$1.48M Buy
11,555
+7,081
+158% +$873K 0.2% 102
2020
Q4 		$533K Buy
4,474
+68
+2% +$8.29K 0.07% 181
2020
Q3 		$504K Sell
4,406
-31
-0.7% -$3.66K 0.08% 177
2020
Q2 		$506K Sell
4,437
-1,132
-20% -$120K 0.08% 171
2020
Q1 		$447K Buy
5,569
+746
+15% +$77.2K 0.08% 187
2019
Q4 		$515K Sell
4,823
-824
-15% -$85.9K 0.08% 204
2019
Q3 		$604K Buy
5,647
+169
+3% +$17.3K 0.09% 186
2019
Q2 		$558K Buy
5,478
+1,962
+56% +$189K 0.07% 201
2019
Q1 		$316K Buy
+3,516
New +$305K 0.04% 260

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ACG Wealth's DGX Position: Q3 2022 in Review

ACG Wealth increased its Quest Diagnostics (DGX) stake by 1% in Q3 2022, buying an estimated $22.5K and bringing the position to 16,754 shares worth $2.06M. The position accounts for 0.47% of the portfolio, ranked #64.

ACG Wealth first reported a position in DGX in Q1 2019 and has held it in 15 quarters since. The position peaked at $2.51M in Q4 2021. 808 funds tracked by Wall St. Rank hold DGX as of Q3 2022.

  • ACG Wealth held 16,754 shares of Quest Diagnostics worth $2.06M as of Q3 2022.
  • ACG Wealth bought 171 Quest Diagnostics shares in Q3 2022, an estimated $22.5K.
  • Quest Diagnostics made up 0.47% of ACG Wealth's portfolio in Q3 2022, its #64 holding.
  • ACG Wealth first reported a position in Quest Diagnostics in Q1 2019 and has held it in 15 quarters since.
  • ACG Wealth's Quest Diagnostics position peaked at $2.51M in Q4 2021.
  • 808 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.